BrainsWay Ltd. (TLV:BWAY)
2,528.00
-122.00 (-4.60%)
Aug 28, 2025, 5:24 PM IDT
BrainsWay Revenue
BrainsWay had revenue of $12.63M USD in the quarter ending June 30, 2025, with 26.26% growth. This brings the company's revenue in the last twelve months to $46.08M, up 26.50% year-over-year. In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth.
Revenue (ttm)
$46.08M
Revenue Growth
+26.50%
P/S Ratio
6.15
Revenue / Employee
$384.03K
Employees
120
Market Cap
955.67M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 56.02B |
Danel (Adir Yeoshua) | 2.84B |
Kamada | 571.15M |
Bait Bakfar | 106.25M |
SofWave Medical | 234.12M |
Novolog (Pharm-Up 1966) | 2.09B |
Ilex Medical | 922.54M |
InterCure | 238.85M |
BrainsWay News
- 7 days ago - BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. - GlobeNewsWire
- 8 days ago - BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health - GlobeNewsWire
- 15 days ago - BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 16 days ago - BrainsWay Q2 2025 Earnings Preview - Seeking Alpha
- 2 months ago - BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) - GlobeNewsWire
- 2 months ago - BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego - GlobeNewsWire
- 3 months ago - BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC - GlobeNewsWire